Schedule 13D ownership disclosure

Arcutis Biotherapeutics Inc

Security class unavailable · CUSIP: 03969K108

Event date: 2023-10-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-264081
Form type
SC 13D/A
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Oct 26, 2023
Reporting period
Oct 24, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub